ATF2 loss promotes 5-FU resistance in colon cancer cells via activation of the ATR-Chk1 damage response pathway

[1]  Sushmita Paul,et al.  ATF2 loss promotes tumor invasion in colorectal cancer cells via upregulation of cancer driver TROP2 , 2022, Cellular and Molecular Life Sciences.

[2]  T. Guecheva,et al.  Analyzing the Opportunities to Target DNA Double-Strand Breaks Repair and Replicative Stress Responses to Improve Therapeutic Index of Colorectal Cancer , 2021, Cancers.

[3]  Mark R. Johnson,et al.  Transcription factors regulated by cAMP in smooth muscle of the myometrium at human parturition , 2021, Biochemical Society transactions.

[4]  B. Lin,et al.  Sequential and co-occurring DNA damage response genetic mutations impact survival in stage III colorectal cancer patients receiving adjuvant oxaliplatin-based chemotherapy , 2021, BMC cancer.

[5]  Akira Sato,et al.  Molecular Mechanisms and Tumor Biological Aspects of 5-Fluorouracil Resistance in HCT116 Human Colorectal Cancer Cells , 2021, International journal of molecular sciences.

[6]  Resham Bhattacharya,et al.  Reality CHEK: Understanding the biology and clinical potential of CHK1. , 2020, Cancer letters.

[7]  Y. Zou,et al.  PP2A Regulates Phosphorylation-Dependent Isomerization of Cytoplasmic and Mitochondrial-Associated ATR by Pin1 in DNA Damage Responses , 2020, Frontiers in Cell and Developmental Biology.

[8]  A. Rogalska,et al.  Participation of the ATR/CHK1 pathway in replicative stress targeted therapy of high-grade ovarian cancer , 2020, Journal of Hematology & Oncology.

[9]  S. Zha,et al.  ATM, ATR and DNA-PKcs kinases—the lessons from the mouse models: inhibition ≠ deletion , 2020, Cell & Bioscience.

[10]  R. Schneider-Stock,et al.  The activating transcription factor 2: an influencer of cancer progression , 2019, Mutagenesis.

[11]  V. Rotter,et al.  Gain-of-Function Mutant p53: All the Roads Lead to Tumorigenesis , 2019, International journal of molecular sciences.

[12]  K. Sugimoto,et al.  Activation of ATR-related protein kinase upon DNA damage recognition , 2019, Current Genetics.

[13]  A. Hartmann,et al.  Combination of 5-fluorouracil and thymoquinone targets stem cell gene signature in colorectal cancer cells , 2019, Cell Death & Disease.

[14]  A. Bardelli,et al.  Exploiting DNA repair defects in colorectal cancer , 2019, Molecular oncology.

[15]  M. Inagaki,et al.  Chk1-mediated Cdc25A degradation as a critical mechanism for normal cell cycle progression , 2019, Journal of Cell Science.

[16]  W. Gmeiner,et al.  Thymineless Death by the Fluoropyrimidine Polymer F10 Involves Replication Fork Collapse and Is Enhanced by Chk1 Inhibition , 2018, Neoplasia.

[17]  A. Hartmann,et al.  Generation and characterization of hepatocellular carcinoma cell lines with enhanced cancer stem cell potential , 2018, Journal of cellular and molecular medicine.

[18]  A. Hartmann,et al.  Cytoplasmic p21 Mediates 5-Fluorouracil Resistance by Inhibiting Pro-Apoptotic Chk2 , 2018, Cancers.

[19]  Wei Tian,et al.  CASTp 3.0: computed atlas of surface topography of proteins , 2018, Nucleic Acids Res..

[20]  Z. Ronai,et al.  ATF2, a paradigm of the multifaceted regulation of transcription factors in biology and disease , 2017, Pharmacological research.

[21]  Kang Liu,et al.  Mutant p53 perturbs DNA replication checkpoint control through TopBP1 and Treslin , 2017, Proceedings of the National Academy of Sciences.

[22]  Dima Kozakov,et al.  The ClusPro web server for protein–protein docking , 2017, Nature Protocols.

[23]  A. Massey.  Inhibition of ATR-dependent feedback activation of Chk1 sensitises cancer cells to Chk1 inhibitor monotherapy. , 2016, Cancer letters.

[24]  J. Dempsey,et al.  LY2606368 Causes Replication Catastrophe and Antitumor Effects through CHK1-Dependent Mechanisms , 2015, Molecular Cancer Therapeutics.

[25]  Frances M. G. Pearl,et al.  Therapeutic opportunities within the DNA damage response , 2015, Nature Reviews Cancer.

[26]  R. Schneider-Stock,et al.  Thymoquinone-induced conformational changes of PAK1 interrupt prosurvival MEK-ERK signaling in colorectal cancer , 2014, Molecular Cancer.

[27]  B. Yoo,et al.  The Regulatory Role of Activating Transcription Factor 2 in Inflammation , 2014, Mediators of inflammation.

[28]  Youwei Zhang,et al.  Roles of Chk1 in cell biology and cancer therapy , 2014, International journal of cancer.

[29]  R. Schneider-Stock,et al.  ATF2 knockdown reinforces oxidative stress-induced apoptosis in TE7 cancer cells , 2013, Journal of cellular and molecular medicine.

[30]  Neus Visa,et al.  The effects of 5-fluorouracil on the proteome of colon cancer cells. , 2013, Journal of proteome research.

[31]  Jinhui Wang,et al.  Gene expression variations in microsatellite stable and unstable colon cancer cells. , 2012, The Journal of surgical research.

[32]  M. Tomasson,et al.  Molecular-Targeted Therapies for Hematologic Malignancies , 2011, Advances in hematology.

[33]  J. Schellens,et al.  Abrogation of the G2 checkpoint by inhibition of Wee-1 kinase results in sensitization of p53-deficient tumor cells to DNA-damaging agents. , 2010, Current clinical pharmacology.

[34]  J. Bartek,et al.  The DNA-damage response in human biology and disease , 2009, Nature.

[35]  Xiao-Fan Wang,et al.  Reduced ATR or Chk1 expression leads to chromosome instability and chemosensitization of mismatch repair-deficient colorectal cancer cells. , 2009, Molecular biology of the cell.

[36]  Carolina Wählby,et al.  BlobFinder, a tool for fluorescence microscopy image cytometry , 2009, Comput. Methods Programs Biomed..

[37]  Hala Gali-Muhtasib,et al.  Thymoquinone triggers inactivation of the stress response pathway sensor CHEK1 and contributes to apoptosis in colorectal cancer cells. , 2008, Cancer research.

[38]  Takamitsu A Kato,et al.  Comparison of the induction and disappearance of DNA double strand breaks and gamma-H2AX foci after irradiation of chromosomes in G1-phase or in condensed metaphase cells. , 2008, Mutation research.

[39]  Narayanaswamy Srinivasan,et al.  Nucleic Acids Research Advance Access published June 21, 2007 PIC: Protein Interactions Calculator , 2007 .

[40]  G. Zachos,et al.  Chk1-dependent slowing of S-phase progression protects DT40 B-lymphoma cells against killing by the nucleoside analogue 5-fluorouracil , 2006, Oncogene.

[41]  Ze'ev Ronai,et al.  ATM-dependent phosphorylation of ATF2 is required for the DNA damage response. , 2005, Molecular cell.

[42]  Michael McClelland,et al.  Identification of promoters bound by c-Jun/ATF2 during rapid large-scale gene activation following genotoxic stress. , 2004, Molecular cell.

[43]  R. Schneider-Stock,et al.  Thymoquinone extracted from black seed triggers apoptotic cell death in human colorectal cancer cells via a p53-dependent mechanism. , 2004, International journal of oncology.

[44]  D. Mercola,et al.  The Activation of c-Jun NH2-terminal Kinase (JNK) by DNA-damaging Agents Serves to Promote Drug Resistance via Activating Transcription Factor 2 (ATF2)-dependent Enhanced DNA Repair* , 2003, Journal of Biological Chemistry.

[45]  David J. Chen,et al.  DNA-dependent protein kinase suppresses double-strand break-induced and spontaneous homologous recombination , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[46]  Y. Furukawa,et al.  Inactivation of the p53 protein in cell lines derived from human esophageal cancers , 1997, International journal of cancer.

[47]  O. Kepp,et al.  Clonogenic Assays to Detect Cell Fate in Mitotic Catastrophe. , 2021, Methods in molecular biology.

[48]  R. Schneider-Stock,et al.  ATF 2 knockdown reinforces oxidative stress-induced apoptosis in TE 7 cancer cells , 2013 .

[49]  Xiao-Fan Wang,et al.  Reduced ATR or Chk 1 Expression Leads to Chromosome Instability and Chemosensitization of Mismatch Repair – deficient Colorectal Cancer Cells , 2009 .

[50]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[51]  N. Guex,et al.  SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling , 1997, Electrophoresis.